NCT02051738View on ClinicalTrials.gov

A Study to Assess the Effect of Food on the Bioavailability of Mebendazole From a Fast-Disintegrating Chewable Formulation of Mebendazole in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Healthy
Interventions
DRUG

Mebendazole - fasted state (Treatment A)

Participants will receive a single 500 mg dose of mebendazole fast-disintegrating chewable tablet in the fasted condition.

DRUG

Mebendazole - fed state (Treatment B)

Participants will receive a single 500 mg dose of mebendazole fast-disintegrating chewable tablet in the fed condition.

Trial Locations (1)

Unknown

Merksem

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT02051738 - A Study to Assess the Effect of Food on the Bioavailability of Mebendazole From a Fast-Disintegrating Chewable Formulation of Mebendazole in Healthy Participants | Biotech Hunter | Biotech Hunter